Therapeutic monitoring of vancomycin

Archives of Pathology and Laboratory Medicine

Volumn 124, Issue 2, 2000, Pages 322-323

  Palmer Toy, Darryl Erik ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG MONITORING; DRUG PROTEIN BINDING; ERYTHEMA; HUMAN; HYPOTENSION; NEPHROTOXICITY; OTOTOXICITY; PHLEBITIS; PRURITUS; SHORT SURVEY;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG MONITORING; ENTEROCOCCUS; HUMANS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0033953094     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (7)

1. Willhelm MP. Vancomycin. Mayo Clin Proc. 1991;66:1165-1170.
2. Fernandez de Gatta MM, Fruns I, Calvo MV, Lanao JM, Dominguez-Gil A. Influence of pharmacokinetic model on vancomycin peak concentration targets. Ther Drug Monit. 1996;18:145-148.
3. Ducharme MP, Slaughter RL, Edwards DJ. Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight. Ther Drug Monit. 1994;16:513-518.
4. Le Normand Y, Milpied N, Kergueris MF, Harousseau JL. Pharmacokinetic parameters of vancomycin for therapeutic regimens in neutropenic adult patients. Int J Biomed Comput. 1994;36:121-125.
5. Cantú TG, Yamanaka-Yuen NA, Leitman PS. Serum vancomycin concentrations: reappraisal of their clinical value. Clin Infect Dis. 1994;18:533-543.
6. Wegener HC, Madsen M, Nielsen N, Aarestrup FM. Isolation of vancomycin resistant Enterococcus becium (VREF) from food. Int J Food Microbiol. 1997;35:57-66.
7. Das I, Fraise A, Wise R. Are glycopeptide-resistant enterococci in animals a threat to human beings? Lancet. 1997;349:997-998.